Guangdong VTR Bio-Tech Co., Ltd. (SHE:300381)
China · Delayed Price · Currency is CNY 6.41
-0.28 (-4.19%)
Jun 2, 2026, 3:04 PM CST
Guangdong VTR Bio-Tech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 3,078 | 3,131 | 3,371 | 3,532 | 3,686 | 5,817 | |
Market Cap Growth | -13.50% | -7.12% | -4.55% | -4.20% | -36.63% | 9.40% |
Enterprise Value | 2,606 | 2,595 | 2,605 | 2,480 | 2,329 | 6,759 |
Last Close Price | 6.41 | 6.52 | 6.93 | 7.20 | 7.34 | 11.31 |
PE Ratio | - | - | 108.42 | - | 202.19 | - |
Forward PE | - | 14.76 | 14.76 | 14.76 | 14.76 | 14.76 |
PS Ratio | 3.65 | 3.76 | 4.08 | 4.44 | 3.14 | 3.07 |
PB Ratio | 1.18 | 1.21 | 1.27 | 1.29 | 1.31 | 1.91 |
P/TBV Ratio | 1.39 | 1.44 | 1.53 | 1.60 | 1.58 | 2.95 |
P/FCF Ratio | - | - | - | - | 70.90 | 107.82 |
P/OCF Ratio | 19.51 | 25.86 | 48.72 | 22.87 | 14.76 | 26.82 |
EV/Sales Ratio | 3.09 | 3.12 | 3.15 | 3.12 | 1.98 | 3.57 |
EV/EBITDA Ratio | 21.46 | 23.82 | 22.55 | 29.94 | 47.57 | 35.88 |
EV/EBIT Ratio | - | - | 1086.69 | - | - | 329.18 |
EV/FCF Ratio | -21.82 | - | - | - | 44.79 | 125.28 |
Debt / Equity Ratio | 0.01 | 0.02 | 0.01 | 0.05 | 0.05 | 0.28 |
Debt / EBITDA Ratio | 0.15 | 0.57 | 0.30 | 1.54 | 3.07 | 4.48 |
Debt / FCF Ratio | - | - | - | - | 2.92 | 15.64 |
Net Debt / Equity Ratio | -0.20 | -0.21 | -0.29 | -0.40 | -0.50 | 0.19 |
Net Debt / EBITDA Ratio | -4.26 | -5.07 | -6.61 | -13.33 | -28.80 | 3.03 |
Net Debt / FCF Ratio | 4.34 | 3.54 | 2.48 | 4.61 | -27.12 | 10.58 |
Asset Turnover | 0.29 | 0.28 | 0.27 | 0.25 | 0.31 | 0.41 |
Inventory Turnover | 2.18 | 2.32 | 2.36 | 2.29 | 1.36 | 1.19 |
Quick Ratio | 3.60 | 3.01 | 4.27 | 4.77 | 7.30 | 0.74 |
Current Ratio | 4.91 | 3.97 | 5.29 | 5.49 | 8.21 | 1.67 |
Return on Equity (ROE) | -0.24% | -0.71% | 1.19% | 0.04% | 1.28% | -2.71% |
Return on Assets (ROA) | -0.21% | -0.40% | 0.05% | -0.57% | -1.45% | 0.28% |
Return on Invested Capital (ROIC) | -0.47% | -0.95% | 0.14% | -1.71% | -1.26% | 0.56% |
Return on Capital Employed (ROCE) | -0.40% | -0.70% | 0.10% | -1.00% | -3.00% | 0.60% |
Earnings Yield | -0.27% | -0.63% | 0.92% | -0.30% | 0.50% | -2.04% |
FCF Yield | -3.88% | -4.99% | -9.14% | -6.79% | 1.41% | 0.93% |
Dividend Yield | 0.75% | 0.77% | 1.44% | 0.83% | 1.36% | 0.88% |
Payout Ratio | - | - | 111.13% | - | 339.73% | - |
Buyback Yield / Dilution | 0.11% | -0.08% | 0.09% | -0.15% | 0.01% | -4.75% |
Total Shareholder Return | 0.88% | 0.69% | 1.54% | 0.68% | 1.37% | -3.87% |